Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 10, 2017, Pages

  Shah, Sachin S ^a   Ohlsson, Arne ^b   Halliday, Henry L ^c   Shah, Vibhuti S ^b  

^a Surya Hospital for Women and Children   (India)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; GLUCOSE; OXYGEN; PLACEBO; BECLOMETASONE; DEXAMETHASONE; GLUCOCORTICOID; RESPIRATORY TRACT AGENT;

ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHILD DEVELOPMENT; CONFLICT OF INTEREST; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INFANT; INFANT MORTALITY; IRELAND; LENGTH OF STAY; LUNG DYSPLASIA; META ANALYSIS; NECROTIZING ENTEROCOLITIS; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEPSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UNITED KINGDOM; VERY LOW BIRTH WEIGHT; CHRONIC DISEASE; INHALATIONAL DRUG ADMINISTRATION; MORTALITY; NEWBORN;

ADMINISTRATION, INHALATION; BECLOMETHASONE; BRONCHOPULMONARY DYSPLASIA; CHRONIC DISEASE; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RESPIRATORY SYSTEM AGENTS;

EID: 85031507720     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD002057.pub4     Document Type: Review

References (62)

1. Halliday HL, Patterson CC, Halahakoon CW, European Multicenter Steroid Study Group. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics 2001;107(2):232-40. 2623252
2. Wilson TT. Long Term Neurodevelopmental and Psychosocial Outcomes Following Premature Birth: Has Postnatal Corticosteroid Treatment Been an Over-looked Factor? [PhD thesis]. Belfast (UK): Queen's University Belfast, 2005. 6863358
3. Wilson TT, Waters L, Patterson CC, McCusker CG, Rooney NM, Marlow N, et al. Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics 2006;117(6):2196-205. 6863357
4. Rozycki HJ, Byron PR, Elliott GR, Carroll T, Gutcher GR. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Pediatric Pulmonology 2003;35(5):375-83. 2623254
5. Suchomski SJ, Cummings JJ. A randomised trial of inhaled versus intravenous steroids in ventilator dependent preterm infants. Journal of Perinatology 2002;22(3):196-203. 2623256
6. Dimitriou G, Greenhough A, Giffin FJ, Kavadia V. Inhaled versus systemic steroids in chronic oxygen dependency of preterm infants. European Journal of Pediatrics 1997;156(1):51-5. 2623258
7. Nicholl RM, Greenough A, King M, Cheeseman P, Gamsu HR. Growth effects of systemic versus inhaled steroids in chronic lung disease. Archives of Disease in Childhood 2002;87(1):F59-61. 2623260
8. American Academy of Pediatrics, Committee on Fetus and Newborn, Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109(2):330-8.
9. Arnon S, Grigg J, Nikander K, Silverman M. Delivery of micronized budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit. Pediatric Pulmonology 1992;13(3):172-5.
10. Avery GB, Fletcher AB, Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75(1):106-11.
11. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD001456.pub2]
12. Bassler D, Plavka R, Shinvell ES, Hallman M, Jarreau PH, Carnielli V, et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. New England Journal of Medicine 2015;573(16):1497-506.
13. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotising enterocolitis: Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187(1):1-7.
14. Bhuta T, Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Archives of Disease in Childhood 1998;79(1):26-33.
15. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo controlled trial. Pediatrics 1991;88(3):421-7.
16. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New England Journal of Medicine 1989;320(23):1505-10.
17. Davis PG, Henderson-Smart DJ. Intravenous dexamethasone for extubation of newborn infants. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000308]
18. Doyle LW, Halliday HL, Ehrenkranz RA. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD001146.pub4]
19. Doyle LW, Halliday HL, Ehrencranz RA. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD001145.pub3]
20. Doyle LW, Cheong JLY. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Who might benefit?. Seminars in Fetal & Neonatal Medicine 2017;22(5):290-5. [DOI: 10.1016/j.siny.2017.07.003; PUBMED: 28734731]
21. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 23 February 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
22. Grigg J, Arnon S, Jones T, Clarke A, Silverman M. Delivery of therapeutic aerosols to intubated babies. Archives of Disease in Childhood 1992;67(1 Spec No):25-30.
23. Gupta GK, Cole CH, Abbasi S, Demissie S, Nijnimbam C, Nielsen HC. Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL8 and IL-Ira in ventilated preterm infants at risk for bronchopulmonary dysplasia. Pediatric Pulmonology 2000;30(4):275-81.
24. Halliday HL. Clinical trials of postnatal steroids: inhaled and systemic. Biology of the Neonate 1999;76(Suppl 1):29-40.
25. Halliday HL. Guidelines on neonatal steroids. Prenatal and Neonatal Medicine 2001;6(6):371-3.
26. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator-and-oxygen- dependent infants: a controlled trial. Journal of Pediatrics 1989;115(6):979-83.
27. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. Cochrane Collaboration.
28. Ibrahim H, Sinha IP, Subhedar NV. Corticosteroids for treating hypotension in preterm infants. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD003662.pub4]
29. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Archives of Ophthalmology 1984;102:1130-4.
30. Jefferies AL. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Journal of Paediatrics and Child Health 2012;17(10):573-4.
31. Johnson JW, Mitzner W, London WT, Palmer AE, Scott R. Betamethasone and the rhesus fetus: multisystemic effects. American Journal of Obstetrics and Gynecology 1979;133(6):677-84.
32. Kazzi NJ, Brans YW, Poland RL. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics 1990;86(5):722-7.
33. Kelly EN, Shah VS, Levenbach J, Vincer M, DaSilva O, Shah PS, Canadian Neonatal Network and Canadian Neonatal Follow-Up Network Investigators. Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates. Journal of Maternal-fetal & Neonatal Medicine 2017 July 16 [Epub ahead of print]. [DOI: 10.1080/14767058.2017.1350644; PUBMED: 28714339]
34. Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, et al. Variations in practice and outcomes in the Canadian NICU Network: 1996-1997. Pediatrics 2000;106(5):1070-9.
35. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001;107(1):E1.
36. Nelin LD, Logan JW. The use of inhaled corticosteroids in chronically ventilated preterm infants. Seminars in Fetal & Neonatal Medicine 2017;22(5):296-301. [DOI: 10.1016/j.siny.2017.07.005; PUBMED: 28768578]
37. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Archives of Disease in Childhood 1993;68(3 Spec No):330-6.
38. O'Callaghan C, Hardy J, Stammers J, Stephensen T, Hull D. Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Archives of Disease in Childhood 1992;67(1 Spec No):20-4.
39. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG 3rd, et al. Randomized placebo-controlled trial of a 42 day tapering course of dexamethasone to reduce the duration of ventilatory dependency in very low birth weight infants: outcomes of study participants at 1-year adjusted age. Pediatrics 1999;104(1 Pt 1):15-21.
40. Ohlsson A, Calvert SA, Hosking M, Shennan AT. Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilatory dependent chronic lung disease. Acta Paediatrica 1992;81(10):751-6.
41. Onland W, Offringa M, van Kaam A. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews 2017, Issue 8. [DOI: 10.1002/14651858.CD002311.pub4]
42. Onland W, De Jaegere APMC, Offringa M, van Kaam A. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD010941.pub2]
43. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1, 500 grams. Journal of Pediatrics 1978;92(4):529-34.
44. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
45. Roberts D, Brown J, Medley N, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2017, Issue 3. [DOI: 10.1002/14651858.CD004454.pub3]
46. Saarela T, Vaarala A, Lanning P, Koivisto M. Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birth-weight infants. Acta Paediatrica 1999;86(6):655-60.
47. Schünemann H, Brozek J, Guyatt G, Oxman A (eds), GRADE Working Group. GRADE Handbook 2013. gdt.gradepro.org/app/handbook/handbook.html (accessed prior to 8 September 2017).
48. Shah V, Ohlsson A. Postnatal dexamethasone in the prevention of chronic lung disease. In: David TJ editor(s). Recent Advances in Paediatrics. London, England: Churchill Livingstone, 2001:77-96.
49. Shah SS, Ohlsson A, Halliday H, Shah VS. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD002058.pub2]
50. Shah VS, Ohlsson A, Halliday HL, Dunn M. Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD001969.pub4]
51. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blaazer S, Bader D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Archives of Disease in Childhood Fetal Neonatal Edition 2000;83(3):F177-81.
52. Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D. Inhaled corticosteroids for bronchopulmonary dysplasia: A meta-analysis. Pediatrics 2016;138(6):e20162511.
53. Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 1990;86(5):728-36.
54. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 3. [DOI: 10.1002/14651858.CD001149]
55. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran EF, et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine 2001;344(2):95-101.
56. Ward MC, Sinn JKH. Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003485]
57. Watterberg KL, American Academy of Pediatrics. Committee of Fetus and Newborn. Policy statement - postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics 2010;126(4):800-8.
58. Weichsel ME Jr. The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Annals of Neurology 1977;2(5):364-6.
59. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, et al. Early dexamethasone therapy in preterm infants: a follow up study. Pediatrics 1998;101(5):E7.
60. Zubrow A, Hulman S, Kushner H, Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. Journal of Perinatology 1995;15(6):470-9.
61. Shah SS, Ohlsson A, Halliday H, Shah VS. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD002057]
62. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD002057.pub3]